Arrowhead Pharmaceuticals (ARWR) Q4 2024 Earnings

26NovConfirmed
Q1 2024
Q2 2024
Q3 2024
Q4 2024
-1.38
-1.08
-0.77
-0.47

Details

Expected EPS
-1.120425
Actual EPS
-1.36
Surprise EPS
-0.24
Surprise Percent
+21.38%

Description

Arrowhead Pharmaceuticals (ARWR) has reported earnings of -1.36 per share for Q4 2024.

0 Comments

Share your thoughts